164 related articles for article (PubMed ID: 38214600)
1. Assessing Adherence to US LI-RADS Follow-up Recommendations in Vulnerable Patients Undergoing Hepatocellular Carcinoma Surveillance.
Choi HH; Kim S; Shum DJ; Huang CY; Shui A; Fox RK; Khalili M
Radiol Imaging Cancer; 2024 Jan; 6(1):e230118. PubMed ID: 38214600
[TBL] [Abstract][Full Text] [Related]
2. Effectiveness of US Surveillance of Hepatocellular Carcinoma in Chronic Hepatitis B: US LI-RADS Visualization Score.
Park MK; Lee DH; Hur BY; Lee HC; Lee YB; Yu SJ; Kim YJ; Yoon JH; Lee JH
Radiology; 2023 Jun; 307(5):e222106. PubMed ID: 37249427
[TBL] [Abstract][Full Text] [Related]
3. Validation of US Liver Imaging Reporting and Data System Version 2017 in Patients at High Risk for Hepatocellular Carcinoma.
Son JH; Choi SH; Kim SY; Jang HY; Byun JH; Won HJ; Lee SJ; Lim YS
Radiology; 2019 Aug; 292(2):390-397. PubMed ID: 31210614
[TBL] [Abstract][Full Text] [Related]
4. Ultrasound (US) LI-RADS: Outcomes of Category US-3 Observations.
Sevco TJ; Masch WR; Maturen KE; Mendiratta-Lala M; Wasnik AP; Millet JD
AJR Am J Roentgenol; 2021 Sep; 217(3):644-650. PubMed ID: 34259543
[No Abstract] [Full Text] [Related]
5. ACR Ultrasound Liver Reporting and Data System: Multicenter Assessment of Clinical Performance at One Year.
Millet JD; Kamaya A; Choi HH; Dahiya N; Murphy PM; Naveed MZ; O'Boyle M; Parra LA; Perez MG; Pirmoazen AM; Rodgers SK; Wasnik AP; Maturen KE
J Am Coll Radiol; 2019 Dec; 16(12):1656-1662. PubMed ID: 31173745
[TBL] [Abstract][Full Text] [Related]
6. Outcomes of LI-RADS US-2 Subthreshold Observations Detected on Surveillance Ultrasound.
Tse JR; Shen L; Bird KN; Yoon L; Kamaya A
AJR Am J Roentgenol; 2022 Nov; 219(5):774-783. PubMed ID: 35703411
[No Abstract] [Full Text] [Related]
7. CT/MRI and CEUS LI-RADS Major Features Association with Hepatocellular Carcinoma: Individual Patient Data Meta-Analysis.
van der Pol CB; McInnes MDF; Salameh JP; Levis B; Chernyak V; Sirlin CB; Bashir MR; Allen BC; Burke LMB; Choi JY; Choi SH; Forner A; Fraum TJ; Giamperoli A; Jiang H; Joo I; Kang Z; Kierans AS; Kang HJ; Khatri G; Kim JH; Kim MJ; Kim SY; Kim YY; Kwon H; Lee JM; Lewis SC; McGinty KA; Mulazzani L; Park MS; Piscaglia F; Podgórska J; Reiner CS; Ronot M; Rosiak G; Song B; Song JS; Tang A; Terzi E; Wang J; Wang W; Wilson SR; Yokoo T
Radiology; 2022 Feb; 302(2):326-335. PubMed ID: 34783596
[TBL] [Abstract][Full Text] [Related]
8. HCC screening with ultrasound: assessment of quality using ultrasound LI-RADS score.
King MJ; Lee KM; Rosberger S; Huang HH; Meza GH; Lewis S; Taouli B
Abdom Radiol (NY); 2023 Jan; 48(1):263-270. PubMed ID: 36243829
[TBL] [Abstract][Full Text] [Related]
9. Diagnostic Accuracy of CEUS LI-RADS for the Characterization of Liver Nodules 20 mm or Smaller in Patients at Risk for Hepatocellular Carcinoma.
Huang JY; Li JW; Lu Q; Luo Y; Lin L; Shi YJ; Li T; Liu JB; Lyshchik A
Radiology; 2020 Feb; 294(2):329-339. PubMed ID: 31793849
[TBL] [Abstract][Full Text] [Related]
10. Role of US LI-RADS in the LI-RADS Algorithm.
Rodgers SK; Fetzer DT; Gabriel H; Seow JH; Choi HH; Maturen KE; Wasnik AP; Morgan TA; Dahiya N; O'Boyle MK; Kono Y; Sirlin CB; Kamaya A
Radiographics; 2019; 39(3):690-708. PubMed ID: 31059393
[TBL] [Abstract][Full Text] [Related]
11. Liver Imaging Reporting and Data System with MR Imaging: Evaluation in Nodules 20 mm or Smaller Detected in Cirrhosis at Screening US.
Darnell A; Forner A; Rimola J; Reig M; García-Criado Á; Ayuso C; Bruix J
Radiology; 2015 Jun; 275(3):698-707. PubMed ID: 25658038
[TBL] [Abstract][Full Text] [Related]
12. Prevalence of different LI-RADS v2018 categories in high-risk patients undergoing CT- or MRI-based screening for hepatocellular carcinoma.
Shahbazian H; Birnbaum J; Burns PJ; Shabanan SH; Kanmaniraja D; Reinus J; Kamel I; Sirlin CB; Chernyak V
Abdom Radiol (NY); 2023 Dec; 48(12):3696-3702. PubMed ID: 37725110
[TBL] [Abstract][Full Text] [Related]
13. LI-RADS Version 2017 versus Version 2018: Diagnosis of Hepatocellular Carcinoma on Gadoxetate Disodium-enhanced MRI.
Lee SM; Lee JM; Ahn SJ; Kang HJ; Yang HK; Yoon JH
Radiology; 2019 Sep; 292(3):655-663. PubMed ID: 31310175
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of LI-RADS Version 2018 Treatment Response Algorithm for Hepatocellular Carcinoma in Liver Transplant Candidates: Intraindividual Comparison between CT and Hepatobiliary Agent-enhanced MRI.
Bae JS; Lee JM; Yoon JH; Kang HJ; Jeon SK; Joo I; Lee KB; Kim H
Radiology; 2021 May; 299(2):336-345. PubMed ID: 33650901
[TBL] [Abstract][Full Text] [Related]
15. Multicenter Study of ACR Ultrasound LI-RADS Visualization Scores on Serial Examinations: Implications for Surveillance Strategies.
Tiyarattanachai T; Fetzer DT; Kamaya A
AJR Am J Roentgenol; 2022 Sep; 219(3):445-452. PubMed ID: 35383486
[No Abstract] [Full Text] [Related]
16. Simplified LI-RADS for Hepatocellular Carcinoma Diagnosis at Gadoxetic Acid-enhanced MRI.
Kwag M; Choi SH; Choi SJ; Byun JH; Won HJ; Shin YM
Radiology; 2022 Dec; 305(3):614-622. PubMed ID: 35972362
[TBL] [Abstract][Full Text] [Related]
17. LI-RADS: Past, Present, and Future, From the
Marks RM; Masch WR; Chernyak V
AJR Am J Roentgenol; 2021 Feb; 216(2):295-304. PubMed ID: 33052720
[TBL] [Abstract][Full Text] [Related]
18. New Arterial Phase Enhancing Nodules on MRI of Cirrhotic Liver: Risk of Progression to Hepatocellular Carcinoma and Implications for LI-RADS Classification.
Smereka P; Doshi AM; Lavelle LP; Shanbhogue K
AJR Am J Roentgenol; 2020 Aug; 215(2):382-389. PubMed ID: 32432909
[No Abstract] [Full Text] [Related]
19. Associations of Ultrasound LI-RADS Visualization Score With Examination, Sonographer, and Radiologist Factors: Retrospective Assessment in Over 10,000 Examinations.
Fetzer DT; Browning T; Xi Y; Yokoo T; Singal AG
AJR Am J Roentgenol; 2022 Jun; 218(6):1010-1020. PubMed ID: 34910539
[No Abstract] [Full Text] [Related]
20. Contrast ultrasound LI-RADS LR-5 identifies hepatocellular carcinoma in cirrhosis in a multicenter restropective study of 1,006 nodules.
Terzi E; Iavarone M; Pompili M; Veronese L; Cabibbo G; Fraquelli M; Riccardi L; De Bonis L; Sangiovanni A; Leoni S; Zocco MA; Rossi S; Alessi N; Wilson SR; Piscaglia F;
J Hepatol; 2018 Mar; 68(3):485-492. PubMed ID: 29133247
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
